237 related articles for article (PubMed ID: 21537049)
21. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
[TBL] [Abstract][Full Text] [Related]
22. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.
Vasen HF; Hendriks Y; de Jong AE; van Puijenbroek M; Tops C; Bröcker-Vriends AH; Wijnen JT; Morreau H
Dis Markers; 2004; 20(4-5):207-13. PubMed ID: 15528786
[TBL] [Abstract][Full Text] [Related]
23. Economic evaluation of genetic screening for Lynch syndrome in Germany.
Severin F; Stollenwerk B; Holinski-Feder E; Meyer E; Heinemann V; Giessen-Jung C; Rogowski W
Genet Med; 2015 Oct; 17(10):765-73. PubMed ID: 25569434
[TBL] [Abstract][Full Text] [Related]
24. Genetic counseling and cascade genetic testing in Lynch syndrome.
Hampel H
Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
[TBL] [Abstract][Full Text] [Related]
25. Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome?
Song T; Kim MK; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():208-12. PubMed ID: 26298861
[TBL] [Abstract][Full Text] [Related]
26. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
27. Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.
Dinh TA; Rosner BI; Atwood JC; Boland CR; Syngal S; Vasen HF; Gruber SB; Burt RW
Cancer Prev Res (Phila); 2011 Jan; 4(1):9-22. PubMed ID: 21088223
[TBL] [Abstract][Full Text] [Related]
28. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic Gynecologic Surgery at Time of Colectomy Benefits Women with Lynch Syndrome and Colon Cancer: A Markov Cost-Effectiveness Analysis.
Ofshteyn A; Jiang B; Bingmer K; Nakayama JM; Gallego C; Giglia M; Stein SL; Steinhagen E
Dis Colon Rectum; 2020 Oct; 63(10):1393-1402. PubMed ID: 32969882
[TBL] [Abstract][Full Text] [Related]
30. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
[TBL] [Abstract][Full Text] [Related]
31. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
32. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.
Hadley DW; Jenkins JF; Steinberg SM; Liewehr D; Moller S; Martin JC; Calzone KA; Soballe PW; Kirsch IR
J Clin Oncol; 2008 Feb; 26(6):948-54. PubMed ID: 18281669
[TBL] [Abstract][Full Text] [Related]
33. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K
Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523
[TBL] [Abstract][Full Text] [Related]
34. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
[TBL] [Abstract][Full Text] [Related]
35. Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study.
Signoroni S; Tibiletti MG; Ricci MT; Milione M; Perrone F; Pensotti V; Chiaravalli AM; Carnevali I; Morabito A; Bertario L; Vitellaro M
Tumori; 2019 Feb; 105(1):76-83. PubMed ID: 30117378
[TBL] [Abstract][Full Text] [Related]
36. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
Chen YE; Kao SS; Chung RH
PLoS One; 2016; 11(8):e0160599. PubMed ID: 27482709
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
Kwon JS; Sun CC; Peterson SK; White KG; Daniels MS; Boyd-Rogers SG; Lu KH
Cancer; 2008 Jul; 113(2):326-35. PubMed ID: 18506736
[TBL] [Abstract][Full Text] [Related]
39. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
[TBL] [Abstract][Full Text] [Related]
40. Improving identification of lynch syndrome patients: a comparison of research data with clinical records.
Tan YY; McGaughran J; Ferguson K; Walsh MD; Buchanan DD; Young JP; Webb PM; Obermair A; Spurdle AB;
Int J Cancer; 2013 Jun; 132(12):2876-83. PubMed ID: 23225370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
